60 DEGREES PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 204.31 thousand shares as of 2025-01-28, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2026-03-30
- 2025-01-28: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 204.31K shares.
- 2024-02-14: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1.00 shares; Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized as first filed 50.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized as first filed |
|---|---|---|
| 2025-01-28 | 204.31K shares 10-Q · filed 2025-11-13 | |
| 2024-02-14 | 1.00 shares 10-K · filed 2026-03-30 | 50.00 shares 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |